BioCloud’s parent company, Kontrol Energy Corporation, says the technology is a “game-changer” in the fight against COVID-19. It says the heart of the BioCloud device is a detection mechanism it calls a ‘Virus Capture System.’ Samples are collected through the air in a non-invasive proprietary inertial impact viral collider, according to Kontrol.